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The production and release of chemical 
substances into the environment continue 
to increase in modern society. Compounds 
known as endocrine-disrupting chemicals 
(EDCs) are a heterogeneous group of con-
taminants present in the environment and in 
food that may interfere with the endocrine 
and reproductive system even at low doses 
(Kavlock and Ankley 1996). They may bind 
to hormone receptors, interfering with inhibi-
tion of synthesis and/or transport of particular 
hormones (Neubert 1997).
Alkylphenol ethoxylates, among the most 
important EDCs, were introduced in the 
1940s and are a class of non-ionic surfactants 
used in detergents, paints, pesticides, personal 
care products, and plastics (Soto et al. 1991; 
White et al. 1994). These chemicals are dis-
charged into aquatic environments via urban 
and industrial wastewaters, where they are bro-
ken down biologically to nonylphenol ethoxy-
late by-products and to the final degradation 
intermediate nonylphenol (NP) (Rudel et al. 
2003; White et al. 1994). These metabolites 
are also used as intermediates in the chemical 
industry (Müller and Schlatter 1998).
para-Nonylphenol (p-NP), a representa-
tive alkylphenol widely used in detergents, 
emulsifiers, and solubilizers, accumulates in 
the environment, where it acts with estrogen-
like activity (de Weert et al. 2008; Ter Veld 
et al. 2008). Human exposure to p-NP may 
occur by cutaneous absorption, ingestion of 
contaminated food or water, and inhalation 
(Guenther et al. 2003; Monteiro-Riviere et al. 
2000). Several studies have shown that p-NP 
binds to both estrogen receptor isoforms 
(ERα, ERβ), competing with the natural 
estrogen 17β-estradiol (17β-E2) (Kwack et al. 
2002; Soto et al. 1995; White et al. 1994), 
although with less potency (Blom et al. 1998; 
Nagel et al. 1997). Estrogenic activity of 
p-NP has been reported in both in vitro stud-
ies (Soto et al. 1991; White et al. 1994) and 
in vivo studies (Laws et al. 2000). Induction 
of estrogen and progesterone receptor syn-
thesis and proliferation of breast cancer cells 
(MCF-7) have been known since 1991 (Soto 
et al. 1991), and tumorigenesis in estrogen-
sensitive target tissues has been reported in the 
last 10 years (Blair et al. 2000; Sonnenschein 
and Soto 1998). Studies in rats have shown 
that subcutaneous injection of p-NP in late 
pregnancy induces calbindin-D9k (CaBP-9k) 
mRNA and protein expression in maternal 
and neonatal uteri, suggesting its potential 
transfer through the placenta (Hong et al. 
2004a, 2004b). CaBP-9k is a cytosolic 
calcium-binding protein expressed in various 
tissues (e.g., intestine, uterus, and placenta) 
and a marker of estrogenic compounds expo-
sure (Choi et al. 2005). Human placenta is 
an estrogen target tissue expressing both ERα 
and ERβ (Bechi et al. 2006; Fujimoto et al. 
2005; Rama et al. 2004), so it is an interest-
ing model to study the estrogen-like activity 
of p-NP. Using an in vitro model of chorionic 
villous explants, we recently demonstrated 
that p-NP has an estrogen-like activity on 
first-trimester human placenta, with a higher 
potency than 17β-E2 (Bechi et al. 2006). In 
particular, exposure to a low concentration of 
p-NP (10–9 M) caused an increase of tropho-
blast differentiation and cell apoptosis.
Placental establishment and development 
are physiologic processes closely regulated by 
soluble autocrine/paracrine factors, namely, 
cytokines (Makrigiannakis and Minas 2007; 
Robertson et al. 1997; Srivastava et al. 1996). 
They include interferons (IFNs), interleu-
kins (ILs), colony-stimulating factors (CSFs), 
tumor necrosis factors (TNFs), chemokines, 
transforming growth factors, and leukemia 
inhibitory factors (Vilcek and Le 1994). Many 
studies conducted in humans and mice have 
established that a correct balance of cytokines 
at the maternal–fetal interface is an essential 
requirement for proper placental development 
and therefore reproductive success (Chaddha 
et al. 2004; Chaouat et al. 1990; Cross et al. 
1994; Laird et al. 2006; Raghupathy and 
Kalinka 2008). Alkylphenols, particularly 
p-NP, also act in immune T cells by altering 
cytokine synthesis in mice (Iwata et al. 2004; 
Lee et al. 2003, 2004).
The aim of the present study was to inves-
tigate whether in vitro exposure to low con-
centrations of p-NP (from 10–13 to 10–9 M), 
even lower than those found in the environ-
ment (Soares et al. 2008), can interfere with 
placental secretion of cytokines.
Address correspondence to L.R. Paulesu, Department 
of Physiology, University of Siena, Via Aldo Moro, 
53100 Siena, Italy. Telephone: 39-0577-234224. 
Fax: 39-0577-234219. E-mail: paulesu@unisi.it
This work was supported by the European Union 
Sixth Framework, ReProTect (LSHB-CT-2004-
503257).
The authors declare they have no competing 
  financial interests.
Received 9 April 2009; accepted 23 November 
2009.
Environmental Levels of para-Nonylphenol Are Able to Affect Cytokine 
Secretion in Human Placenta
Nicoletta Bechi,1 Francesca Ietta,1 Roberta Romagnoli,1 Silke Jantra,1 Marco Cencini,2 Gianmichele Galassi,3 
Tommaso Serchi,4 Ilaria Corsi,5 Silvano Focardi,5 and Luana Paulesu1
1Department of Physiology, University of Siena, Siena, Italy; 2Obstetrics and Gynecology Division, Hospital, Campostaggia, Siena, Italy; 
3Medical Physics, Department of Physics, 4Department of Clinical Medicine and Immunological Sciences, Rheumatology Unit, and 
5Department of Environmental Sciences, University of Siena, Siena, Italy
Ba c k g r o u n d: para-Nonylphenol (p-NP) is a metabolite of alkylphenols widely used in the chemical 
industry and manufacturing. It accumulates in the environment, where it acts with estrogen-like 
activity. We previously showed that p-NP acts on human placenta by inducing trophoblast differen-
tiation and apoptosis.
oB j e c t i v e: The aim of the present study was to investigate the effect of p-NP on cytokine secretion 
in human placenta.
Me t h o d s : In vitro cultures of chorionic villous explants from human placenta in the first tri-
mester of pregnancy were treated with p-NP (10–13, 10–11, and 10–9 M) in 0.1% ethanol as 
vehicle. Culture medium was collected after 24 hr and assayed by specific immunoassays for the 
cytokines   granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon-γ (IFN-γ), 
interleukin (IL)-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, and tumor necrosis factor-α (TNF-α).
re s u l t s: p-NP modulated cytokine secretion by inducing the release of GM-CSF, IFN-γ, IL-1β, 
IL-4, and IL-10, with a maximum effect at 10–11 M. It reduced the release of TNF-α at 10–13 M, 
whereas levels of IL-2 and IL-5 remained below the detection limit. IL-6 and IL-8 levels were 100–
1,000 times higher than those of other cytokines, and they were not affected by p-NP. We observed 
significant differences from controls (ethanol alone) only for GM-CSF and IL-10.
co n c l u s i o n: An unbalanced cytokine network at the maternal–fetal interface may result in 
implantation failure, pregnancy loss, or other complications. The effects of extremely low doses of 
p-NP on the placental release of cytokines raise considerable concerns about maternal exposure to 
this endocrine disruptor during pregnancy.
key w o r d s : chorionic villous explants, cytokine network, endocrine disruptors, human placenta, 
para-nonylphenol. Environ Health Perspect 118:427–431 (2010).  doi:10.1289/ehp.0900882 avail-
able via http://dx.doi.org/ [Online 23 November 2009]Bechi et al.
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Materials and Methods
Sample collection. Placental tissues from first-
trimester pregnancies (n = 6) were obtained 
at the hospital’s Division of Obstetrics and 
Gynecology (Campostaggia, Siena, Italy). 
Only healthy women who underwent elec-
tive termination of pregnancy at weeks 7–8 
of gestation were included into the study. 
Written informed consent after full explana-
tion of the purpose of the study was obtained 
by the physician from each enrolled patient. 
Gestational age was determined by the date of 
the last menstrual period and ultrasound meas-
urement of crown–rump length. When there 
was a discrepancy of ≥ 7 days between the 
two dating methods, patients were excluded 
from the study. Tissues were rinsed in cold 
phosphate-buffered saline (PBS) to remove 
excessive blood and processed for explant 
cultures within 2 hr. The present study was 
approved by the local ethics committee (Siena, 
May 2004) in accordance with the Helsinki 
Declaration guidelines.
Isolation and treatment of chorionic 
villous explants. Villous explants from pla-
cental tissues were dissected as described by 
Caniggia et al. (1997). Briefly, small fragments 
of villous tips (15–20 mg wet weight) were 
placed on Millicell CM culture dish inserts 
(Millipore Corp., Bedford, MA, USA) previ-
ously coated with 180 µL undiluted Matrigel 
(Collaborative Research, Inc., Bedford, MA, 
USA) and then inserted in 24-well plates and 
left overnight at 37°C in a humidified atmo-
sphere of 95% air/5% CO2 to allow explant 
attachment to the Matrigel. After this time, 
explants were exposed to culture medium con-
taining p-NP (Sigma Chemical Co., St. Louis, 
MO, USA) at 10–13, 10–11, and 10–9 M, or 
only to vehicle (0.1% ethanol; control cul-
tures) for 24 hr. p-NP concentrations and 
incubation time were selected on the basis 
of a report by Bechi et al. (2006) showing 
trophoblast differentiation and cell apoptosis 
on p-NP exposure. The culture medium used 
was Dulbecco’s modified Eagle’s medium/F12 
without phenol red (Gibco, Grand Island, NY, 
USA) supplemented with 100 U/mL peni-
cillin/streptomycin and 2 mM l-glutamine 
(Sigma). At 24 hr of incubation, explants were 
removed from the Matrigel, washed in PBS, 
frozen, and stored at –80°C until processing 
for protein extraction. Culture medium was 
centrifuged at 4°C for 10 min at 10,000 × g, 
divided into aliquots, immediately frozen at 
–80°C, and maintained frozen until analysis 
for cytokines and β-human chorionic gonado-
tropin (β-hCG). In total, six experiments were 
performed, each using a single placenta. p-NP 
treatments and control cultures were carried 
out in triplicate, and samples from separate 
explant cultures were pooled before being pro-
cessed at the end of incubation.
Protein extraction. Pooled villous explants 
from each treatment were homogenized in 
ice-cold lysing buffer (50 mM Tris-HCl, 
50 mM NaCl, 1% Triton X-100, 1% sodium 
deoxycholate, 0.1% sodium dodecyl sulfate) 
containing 100 mM sodium orthovanadate 
and a protease inhibitor cocktail containing 
4-(2-aminoethyl benzenesulfonyl fluoride), 
pepstatin A, E-64, bestatin, leupeptin, and 
aprotinin (Sigma). Protein lysates were clari-
fied by centrifuging at 13,000 × g for 15 min 
at 4°C. Total protein concentration (mg/mL) 
was determined by the Quick Start Bradford 
Protein Assay (Biorad Laboratories, Hercules, 
CA, USA).
Multiplex assay for cytokine quantifica-
tion. Ten cytokines released into the chori-
onic explant culture medium were measured 
simultaneously with the Human Ultrasensitive 
Cytokine 10-Plex Multiplex Bead Immuno-
assay (Invitrogen, Carlsbad, CA, USA) fol-
lowing the manufacturer’s protocol. The range 
of detection was 0.75–549 pg/mL for gran-
ulocyte-macrophage colony–stimulating fac-
tor (GM-CSF), 0.71–515 pg/mL for IFN-γ, 
0.38–274 pg/mL for IL-1β, 0.46–333 pg/mL 
for IL-2, 1.4–1,019 pg/mL for IL-4, 1.26–
916 pg/mL for IL-5, 0.56–409 pg/mL for IL-6, 
0.65–474 pg/mL for IL-8, 0.45–330 pg/mL 
for IL-10, and 0.51–369 pg/mL for TNF-
α. These values represent the lowest and the 
highest limit of detection (LOD) for each 
cytokine, and concentrations outside the 
LOD were not considered for statistical anal-
ysis. We calculated cytokine concentrations in 
the samples using a standard curve established 
from serial dilutions of each cytokine standard 
as described in the manufacturer’s protocol 
and expressed as picograms per milliliter of 
culture medium. Cytokine concentrations 
were normalized to total explant protein con-
tent and expressed as picograms per milligram 
of tissue protein.
β-hCG assay. The concentration of 
β-hCG in the explant culture medium was 
assessed with a commercial immunoenzymo-
metric assay (Radim SpA, Pomezia, Italy) fol-
lowing the manufacturer’s instructions. The 
limit of sensitivity was 2 mIU⁄mL and the 
linear range of detection was 0–2,000 mIU/
mL. The concentration was expressed in milli-
international units per microgram of total 
protein in tissue explants.
Statistical analysis. The effect of p-NP 
on cytokine secretion was expressed as the 
stimulatory index (SI): the ratio between 
the cytokine concentration in the culture 
medium of p-NP–treated explant cultures and 
the corresponding control cultures in each 
experiment. We used SI for statistical analysis 
instead of normalized values to examine dif-
ferences and trends among our data. Analyses 
were performed with SPSS [version 13 (SPSS 
Inc., Chicago, IL, USA) for Mac OS X Tiger 
(version 10.4.11; Apple, Cologno Monzese, 
MI, Italy)].The Shapiro–Wilk test and 
Q-Q plots were used to confirm normality; 
Levene’s test and detrended Q-Q plots were 
respectively used to confirm homo  skedasticity 
and the lack of outliers. Statistically signifi-
cant differences were determined by one-way 
analysis of variance (p ≤ 0.05).
Results
Detection of cytokines. We analyzed 24 
samples, including three p-NP treatments 
(10–13, 10–11, 10–9 M) and one control (eth-
anol 0.1%) from six separate experiments, 
for GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, 
IL-5, IL-6, IL-8, IL-10, and TNF-α by 
means of specific immunoassays. We iden-
tified GM-CSF, IFN-γ, IL-1β, and IL-4 in 
all samples analyzed. We detected IL-10 and 
Table 1. Cytokine concentration (pg/mg total tissue protein) in culture medium from p-NP–treated 
and –untreated chorionic villous explants.
Group GM-CSF IFN-γ IL-1β IL-2 IL-4 IL-5 IL-10 TNF-α IL-6 IL-8
Control
n 6 6 6 6 6 6 5 3 6 6
Mean (pg/mg) 0.5370 0.8438 2.7867 < LOD 1.9622 < LOD 0.1154 0.4214 > LOD > LOD
SD 0.3251 0.7144 1.2905 1.0012 0.0965 0.2841
Variance 0.1060 0.5100 1.6650 1.0020 0.0090 0.0810
p-NP 10–13 M
n 6 6 6 6 6 6 5 3 6 6
Mean (pg/mg) 0.5439 0.7426 2.9217 < LOD 2.2076 < LOD 0.0948 0.2806 > LOD > LOD
SD 0.2215 0.4056 0.9331 0.7652 0.0423 0.1178
Variance 0.0490 0.1650 0.8710 0.5850 0.0020 0.0140
p-NP 10–11 M 
n 6 6 6 6 6 6 5 3 6 6
Mean (pg/mg) 0.7676 1.2933 3.3403 < LOD 2.7319 < LOD 0.1757 0.6541 > LOD > LOD
SD 0.5036 1.0250 1.2457 1.5103 0.1570 0.8087
Variance 0.2540 1.0510 1.5520   2.2810 0.0250 0.6540
p-NP 10–9 M 
n 6 6 6 6 6 6 5 3 6 6
Mean (pg/mg) 0.7337 1.0893 3.3070 < LOD 2.6281 < LOD 0.1904 0.6708 > LOD > LOD
SD 0.4666 0.8686 1.7310 1.8578 0.2024 0.4574
Variance 0.2180 0.7540 2.9960 3.4510 0.0410 0.2090
< LOD and > LOD indicate values outside the detection limit. para-Nonylphenol effects in human placenta
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TNF-α in 83.3% and 50% of all samples, 
respectively, whereas their levels were less 
than the respective LODs, < 0.45 pg/mL 
and < 0.51 pg/mL, in the other samples. IL-2 
and IL-5 were below the respective LODs 
(< 0.46 and < 1.26 pg/mL), whereas IL-6 and 
IL-8 exceeded the respective LODs, > 409 
and > 474 pg/mL, in 100% of the samples 
(Table 1).
Cytokines in p-NP–treated cultures. 
Control cultures of first-trimester human pla-
centa exposed only to vehicle (0.1% ethanol) 
released GM-CSF, IFN-γ, IL-1β, IL-4, IL-6, 
IL-8, IL-10, and TNF-α into the culture 
medium (concentrations and interindividual 
variances reported in Table 1). Because the 
levels of IL-6 and IL-8 were above the LOD 
in all samples examined, we determined the 
concentrations of these cytokines in a separate 
assay running together pure and 1:10 diluted 
samples from a representative experiment. 
The concentrations of IL-6 and IL-8 were 
100–1,000 times higher than those of the 
other cytokines (Figure 1).
Treatment with p-NP for 24 hr increased 
the secretion of GM-CSF, IFN-γ, IL-1β, 
IL-4, and IL-10 with respect to control cul-
tures (Figure 2). We observed a biphasic 
effect of p-NP for TNF-α: It was suppres-
sive at the lowest concentration (10–13 M) 
and stimulatory at the others, with a peak 
at 10–11 M (Figure 2). To reduce the sub-
ject/tissue variability, we expressed data as the 
mean SI [ratio between the cytokine concen-
tration in culture medium of treated explant 
cultures and the corresponding untreated cul-
tures (0.1% ethanol) in each experiment]. We 
observed increasing SIs for GM-CSF, IFN-γ, 
IL-1β, IL-4, TNF-α, and IL-10, with a maxi-
mum effect at 10–9 M p-NP for GM-CSF 
and at 10–11 M p-NP for the other cytok-
ines (Figure 2). The increase was significant 
for GM-CSF and IL-10 (p = 0.045 and p = 
0.011, respectively) at 10–11 M. IL-2 and IL-5 
remained below the LOD (data not shown), 
whereas IL-6 and IL-8 were above the LOD 
and we determined their concentrations in 
a representative experiment as described for 
the control cultures. We observed only slight 
variations for IL-6 and IL-8 with respect to 
the control cultures (data not shown). 
In summary, we found a general stimula-
tory potency of p-NP for GM-CSF, IFN-γ, 
IL-1β, IL-4, TNF-α, and IL-10 at extremely 
low p-NP concentrations, with a suppressive 
effect for TNF-α at 10–13 M p-NP. IL-2 and 
IL-5 were below the LOD in both p-NP–
treated and control cultures. IL-6 and IL-8 
were the most abundant cytokines, but their 
levels were not affected by p-NP treatment. 
We observed significant differences with 
respect to control cultures only for GM-CSF 
and IL-10 (p = 0.045 and p = 0.011, respec-
tively). These results do not exclude possible 
differences for the other cytokines tested; they 
show only that the low number of samples 
containing detectable amounts of some cyto-
kines and the high variability of individual 
measurements did not allow us to highlight 
the differences with a low probability of error.
Detection of β-hCG. We analyzed β-hCG 
secretion, a marker of trophoblast viability, 
by a specific immunoenzymometric assay in 
parallel with the cytokine assays. We detected 
β-hCG in 100% of the samples, with no sig-
nificant difference with respect to control cul-
tures at any of the p-NP concentrations (data 
not shown).
Discussion
Cytokines play a critical role in pregnancy, 
particularly in the early stages during blas-
tocyst implantation and placental develop-
ment (Chaouat et al. 2007; Moffett and Loke 
2006; Paria et al. 2002; Saito 2001; Schäfer-
Somi 2003). Therefore, it is extremely useful 
to study cytokines secreted by the placenta 
in the first trimester of pregnancy, as well as 
potential interfering factors.
Using an in vitro model of chorionic vil-
lous explants, we showed here that p-NP, a 
ubiquitous environmental contaminant with 
estrogenic activity, interfered with first-tri-
mester human placenta cytokine secretion. 
In particular, we assayed a set of 10 cytokines 
(GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, 
IL-6, IL-8, IL-10, and TNF-α) in the culture 
medium of chorionic villous explants exposed 
to p-NP or only to vehicle (control). The find-
ings revealed an increase of GM-CSF, IFN-γ, 
IL-1β, IL-4, and IL-10, with a maximum 
activity at 10–9 M p-NP for GM-CSF and 
10–11 M p-NP for the other cytokines, with a 
significant difference for GM-CSF and IL-10 
at 10–11 M p-NP. TNF-α release was also 
modulated by p-NP treatment with a decrease 
at 10–13 M and an increase at higher p-NP 
concentrations. IL-6 and IL-8, the most abun-
dantly secreted cytokines, were not affected by 
p-NP treatment at any concentration, whereas 
IL-2 and IL-5 were below the detection limit 
in p-NP–treated and untreated placental 
explants. To demonstrate tissue integrity in 
our explant cultures, we verified that β-hCG 
secretion did not change significantly in 
p-NP–treated versus control cultures. β-hCG 
release is a marker of continuous endocrine 
activity of the syncytiotrophoblast, the epithe-
lial layer of chorionic villi forming the placen-
tal barrier (Miller et al. 2005). Using the same 
model of placental explants, we previously 
showed that 10–9 M p-NP had an estrogen-
like effect, in that it increased β-hCG release 
and cellular apoptosis at 48–72 hr of p-NP 
exposure (Bechi et al. 2006). In accordance 
with these previous findings, we found no 
remarkable changes in β-hCG release at 24 hr 
of exposure, even at 10–9 M p-NP, the high-
est concentration used. These data reveal that 
p-NP deregulates cytokine secretion before it 
acts on β-hCG release.
GM-CSF and IL-10, the two cytokines sig-
nificantly affected by p-NP, are important medi-
ators in human pregnancy (Gotsch et al. 2008; 
Figure 1. Representative pie chart of cytokine 
concentrations in the culture medium of chorionic 
villous explants from human placenta at the first 
trimester of pregnancy exposed to 0.1% ethanol for 
24 hr (control cultures). Numbers in parentheses 
are cytokine concentrations (pg/mg total tissue 
protein).
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IFN-γ (0.22)
IL-10 (0.25)
IL-8 (256.96)
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GM-CSF (0.38)
IL-1β (3.42)
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Figure 2. Cytokine secretion in the culture medium 
of chorionic villous explants from first-trimester 
placenta exposed to p-NP at various concentra-
tions for 24 hr. SI is the ratio between the cytokine 
concentration in culture medium of p-NP–treated 
explant cultures and the corresponding control 
cultures (C) in each experiment. Data are the mean 
of experiments including detectable amounts of 
cytokines (n = 6 for GM-CSF, IFN-γ, IL-1β, and 
IL-4; n = 5 for IL-10; n = 3 for TNF-α). A significant 
increase was observed for GM-CSF and IL-10 (*p = 
0.045 and **p = 0.011, respectively).
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Robertson 2007). Indeed, GM-CSF is a pivotal 
factor contributing to normal placental devel-
opment and fetal growth (Robertson 2007). It 
is expressed in early gestation by fetal tropho-
blast and by decidual immune and nonimmune 
cells (Jokhi et al. 1994; Saito et al. 1993). It also 
acts on placental trophoblast cells by inducing 
differentiation into mature syncytiotrophoblast 
and stimulates its secretion of placental lactogen 
and chorionic gonadotropin (Baldwin 1992; 
Garcia-Lloret et al. 1994; Morrish et al. 1998). 
A very recent report by Fukui et al. (2008) 
showed that GM-CSF-producing natural killer 
(NK) cells in the maternal decidua tended to 
be decreased in women with recurrent abortion 
or implantation failure. All these studies suggest 
that GM-CSF is a crucial autocrine/paracrine 
mediator at the maternal–fetal interface regulat-
ing placental growth and its acceptance in the 
maternal uterus.
IL-10 is an anti-inflammatory cytokine 
widely present in tissues and fluids during ges-
tation (Gotsch et al. 2008), including cyto- 
and syncytiotrophoblast as well as decidual 
mononuclear cells/macrophages and NK cells 
(Hanna et al. 2000; Lidstrom et al. 2003). 
High levels of IL-10 have also been found 
in amniotic fluid and in the maternal serum 
(Dudley et al. 1997; Gotsch et al. 2008; Greig 
et al. 1995). IL-10 is one of the cytokines 
produced by T-helper (Th)2 lymphocytes, 
whose immunity is necessary for successful 
fetal outcome. During pregnancy, Th1-driven 
cell-mediated immunity characterized by 
the secretion of IFN-γ, TNF-α, and IL-2 is 
shifted to a Th2-driven humoral immunity 
mainly represented by the secretion of IL-4, 
IL-5, IL-6, and IL-10 (Wegmann et al. 1993). 
Deviation from the Th2-like response leads to 
miscarriage (Raghupathy and Kalinka 2008; 
Tezabwala et al. 1989), and the administration 
of Th1 cytokines in mice has also been shown 
to cause miscarriage (Tezabwala et al. 1989).
The present study shows that Th2 placental 
cytokines (IL-4 and IL-10) are increased by 
p-NP treatment, whereas Th1 cytokines are 
increased, as in the case of IFN-γ, or modulated 
by a decrease or increase depending on the 
p-NP concentration, as in the case of TNF-α. 
These findings agree with Lee et al. (2003) and 
Iwata et al. (2004) in showing an imbalance of 
Th1/Th2 cytokines in immune cells caused by 
p-NP exposure. Specifically, Lee et al. (2003) 
demonstrated that p-NP increased IL-4 pro-
duction in CD4+ T cells and Iwata et al. (2004) 
showed that p-NP and octylphenol had direct 
effects on T cells, suppressing the Th1 and 
enhancing the Th2 cytokine development.
The consequences of this altered bal-
ance at the maternal–fetal interface are not 
known. Literature reports have shown that 
some of the cytokines increased in this study 
(GM-CSF, IL-4, and IL-10) are able to stim-
ulate β-hCG secretion by the trophoblast cells 
(Doria et al. 2006; Nishino et al. 1990; Saito 
et al. 1997). These findings, along with ours, 
suggest that, by altering cytokine balance and 
therefore trophoblast differentiation, p-NP 
exposure in early gestation may contribute 
to faulty placentation, leading to pregnancy 
disorders and fetal growth retardation (Allaire 
et al. 2000; Crocker at al. 2004).
The p-NP concentrations used here are 
in the nano- to picomolar range, well below 
(< 1,000 times) those reported in other in vitro 
systems or those found in humans (Blom 
et al. 1998; Inoue et al. 2000; Kawaguchi 
et al. 2004; Nagel et al. 1997; Tan and Nohd 
2003). To our knowledge, no biological effects 
have been reported for p-NP at concentra-
tions < 1 µM, except for the recent finding 
of a dose-dependent inhibition of aromatase 
activity in human JEG-3 placenta cells in the 
range of 10–9 to 10–5 M (Bonefeld-Jørgensen 
et al. 2007). The present study supports the 
high sensitivity of human placenta to p-NP 
exposure. The most effective concentra-
tion (10–11 M) used in the present study is 
about 2.2 pg/mL, whereas the levels of p-NP 
detected in human samples vary from 0.3 
to 221.7 ng/mL, and in the environment, 
4.1 µg/L in river waters and 1 mg/kg in sedi-
ments (Inoue et al. 2000; Kawaguchi et al. 
2004; Soares et al. 2008). Lower levels have 
been reported (15.17 ng/mL) in human cord 
blood samples (Tan and Nohd 2003).
Conclusion
Our study demonstrates that p-NP at envi-
ronmentally relevant levels affects the cytokine 
balance in human placenta. Environmental 
levels of p-NP may be well above the thresh-
old necessary to induce paracrine disruption 
in human placenta. These results raise concern 
about maternal exposure to this chemical dur-
ing pregnancy and suggest a possible involve-
ment of environmental factors in pregnancy 
complications.
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